SanBio Company Limited
SNBIF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $49,685,125 | $38,374,184 | $41,430,283 | $56,052,211 |
| - Cash | $2,921,402 | $4,454,716 | $6,732,775 | $4,557,006 |
| + Debt | $397,000 | $665,000 | $933,000 | $2,525,000 |
| Enterprise Value | $47,160,723 | $34,584,468 | $35,630,508 | $54,020,205 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$14,504 | -$24,615 | -$132,467 |
| % Margin | – | – | – | – |
| EBITDA | -$3,507,000 | -$4,525,225 | -$4,648,983 | -$4,383,350 |
| % Margin | – | – | – | – |
| Net Income | -$2,882,000 | -$2,644,332 | -$5,559,584 | -$4,677,856 |
| % Margin | – | – | – | – |
| EPS Diluted | -41.85 | -40.48 | -95.99 | -90.33 |
| % Growth | -3.4% | 57.8% | -6.3% | – |
| Operating Cash Flow | -$3,603,106 | -$4,765,654 | -$7,434,147 | -$6,546,664 |
| Capital Expenditures | -$4,891 | -$54,969 | -$8,003 | -$56,077 |
| Free Cash Flow | -$3,607,997 | -$4,820,623 | -$7,442,150 | -$6,602,741 |